Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Therapie|September 1, 2000
Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?P Vandel, E Haffen, S Vandel, et al.
Pharmacopsychiatry|December 22, 1999
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotypeE Haffen, P Vandel, F Broly, et al.
The Journal of Clinical Psychiatry|January 1, 1980
Parenteral loxapine in severely disturbed schizophrenic patientsP Deniker, H Loo, M J Cottereau
L'Encephale|December 16, 1998
[Subthreshold depressive disorders: description and importance for secondary prevention in psychiatry]C Castelnau, J P Olie, H Loo
International Clinical Psychopharmacology|January 25, 2002
Social functioning and quality of life in the schizophrenic patient: advantages of amisulprideP Saleem, J P Olié, H Loo
L'Encephale|June 1, 1997
[Indications for electroconvulsive therapy]J Boiteux, L Roubaud, N Gandelet, et al.
Pharmacological Research|June 1, 1995
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patientsS Vandel, G Bertschy, P Baumann, et al.
L'Encephale|May 1, 1996
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]B Bonin, G Bertschy, P Baumann, et al.
Neuropsychobiology|January 1, 1992
Tricyclic antidepressant plasma levels after fluoxetine additionS Vandel, G Bertschy, B Bonin, et al.
Therapeutic Drug Monitoring|December 29, 2000
Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluationM Gex-Fabry, E Haffen, G Paintaud, et al.
Pageof 18